Beijing Konruns Pharmaceutical Co.,Ltd. (SHSE: 603590)
Health Care · Pharmaceuticals · CN
CN¥30.98
-3.52% today · -37.6% 1Y
Beijing Konruns Pharmaceutical Co.,Ltd. (SHSE: 603590) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $726.21M and employs 793 people.
Over the last twelve months the share price has lost 37.6%, trading between 27.33 and 54.86.
Tweenvest scores Beijing Konruns Pharmaceutical Co.,Ltd. across four factors: quality 74/100, value 58/100, growth 25/100, dividend 29/100. Its strongest factor is quality.
603590 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $726.21M
- Revenue (TTM)
- $135.00M
- P/E
- 28.97
- EPS
- 1.07
- Dividend yield
- 1.13%
- Beta (5Y)
- 0.40
- 52-week high
- CN¥54.86
- 52-week low
- CN¥27.33
- Avg volume (3M)
- —
- Shares outstanding
- 157.01M
- Employees
- 793
- Next earnings
- —
About Beijing Konruns Pharmaceutical Co.,Ltd.
Beijing Konruns Pharmaceutical Co.,Ltd., a Chinese company established in 2003 and based in Beijing, focuses on the discovery, production, and distribution of various pharmaceutical items. Among its key offerings is Su Ling, a hemagglutinin preparation designed to minimize blood loss during surgical procedures and manage post-operative bleeding. The firm is also actively developing a pipeline of potential new medicines, such as CX1026, CX1003, and KC1036.
- ISIN
- CNE1000036K3
- Founded
- 2003
- Listed since
- Aug 27, 2018
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Keyuan Pharmaceutical Co., Ltd.SZSE: 301281 | $743.37M | CN¥45.98 | -2.69% |
| Morepen Laboratories LimitedBSE: 500288 | $734.62M | Rs129.75 | -2.95% |
| Lionco Pharmaceutical Group Co.,Ltd.SHSE: 603669 | $731.05M | CN¥6.96 | +9.95% |
| Yabao Pharmaceutical Group Co., LtdSHSE: 600351 | $730.42M | CN¥7.07 | +3.67% |
| Xinjiang Bai Hua Cun Pharma Tech Co.,LtdSHSE: 600721 | $723.96M | CN¥12.61 | -3.81% |
| Oneness Biotech Co., Ltd.TPEX: 4743 | $721.31M | NT$48.10 | +2.01% |
| Collegium Pharmaceutical, Inc.NasdaqGS: COLL | $719.15M | $22.06 | -0.14% |
| Tibet Duo Rui Pharmaceutical Co., Ltd.SZSE: 301075 | $716.02M | CN¥59.95 | -5.10% |
Figures last refreshed Oct 11, 2026.